Skip to main content
. 2014 Jun 12;2014:481071. doi: 10.1155/2014/481071

Figure 2.

Figure 2

Tornado diagram showing result of deterministic sensitivity analysis for the direct comparison of cost-effectiveness of pazopanib versus placebo. Parameters were varied by 0.5 or 1.5 and shown on either side of the graph. AE: adverse events; CI: confidence interval; OS: overall survival; PFS: progression-free survival; PPS: postprogression survival; PTACT: posttreatment anticancer therapy.